F. Vacondio

P. Carrupt, B. Testa, M. Mor, 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Synthesis, biological activity, QSAR and QSPR study of 2-aminobenzimidazole derivatives as potent H3-antagonists.

M. Mor, M. Impicciatore, V. Ballabeni, 2004, Bioorganic & medicinal chemistry.

The role of HB-donor groups in the heterocyclic polar fragment of H3-antagonists. I. Synthesis and biological assays.

V. Ballabeni, E. Barocelli, S. Bertoni, 2003, Farmaco.

Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups.

M. Mor, M. Impicciatore, V. Ballabeni, 2000, Farmaco.

Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis.

M. Mor, M. Rusnati, M. Incerti, 2016, Biochemical pharmacology.

Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous Solubility.

M. Mor, V. Di Marzo, S. Lamponi, 2016, Journal of medicinal chemistry.

Synthesis and preclinical evaluation of a novel, selective 111In-labelled aminoproline-RGD-peptide for non-invasive melanoma tumor imaging

A. Pupi, F. Bianchini, C. Curti, 2015 .

Structure–Property Relationships of a Class of Carbamate‐Based Fatty Acid Amide Hydrolase (FAAH) Inhibitors: Chemical and Biological Stability

Claudia Silva, Alessandro Fioni, Daniele Piomelli, 2009, ChemMedChem.

Design, Synthesis, Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Anti-Osteoarthritic Activity in Vivo.

M. Mor, V. Di Marzo, S. Lamponi, 2020, Journal of medicinal chemistry.

N‐(Anilinoethyl)amide Melatonergic Ligands with Improved Water Solubility and Metabolic Stability

M. Mor, G. Gobbi, S. Rivara, 2021, ChemMedChem.

5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line.

M. Mor, C. Carmi, P. Petronini, 2009, European journal of medicinal chemistry.

Irreversible inhibition of epidermal growth factor receptor activity by 3-aminopropanamides.

A. Ardizzoni, M. Mor, G. Costantino, 2012, Journal of medicinal chemistry.

2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry.

Marco Pieroni, Elisa Azzali, G. Costantino, 2020, ACS medicinal chemistry letters.

Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors.

A. Duranti, A. Tontini, M. Mor, 2010, Journal of medicinal chemistry.

Synthesis, antioxidant activity and structure–activity relationships for a new series of 2‐(N‐acylaminoethyl)indoles with melatonin‐like cytoprotective activity

Claudia Silva, Marco Mor, Federica Vacondio, 2006, Journal of pineal research.

N-(2-oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships.

A. Duranti, A. Tontini, M. Mor, 2012, Journal of medicinal chemistry.

pH-partition profiles of 4-(3-oxo-1,2-benzisothiazolin-2-yl)phenyl and phenoxyalkanoic acids.

M. Mor, F. Vacondio, Claudia Silva, 2003, Farmaco.

Benzisothiazolinone derivatives as potent allosteric monoacylglycerol lipase inhibitors that functionally mimic sulfenylation of regulatory cysteines.

M. Mor, D. Piomelli, K. Jung, 2019, Journal of medicinal chemistry.

Analysis of illicit dietary supplements sold in the Italian market: identification of a sildenafil thioderivative as adulterant using UPLC-TOF/MS and GC/MS.

M. Mor, Domenico Di Giorgio, F. Vacondio, 2014, Science & justice : journal of the Forensic Science Society.

Epidermal growth factor receptor irreversible inhibitors: chemical exploration of the cysteine-trap portion.

A. Ardizzoni, M. Mor, C. Carmi, 2011, Mini reviews in medicinal chemistry.

Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor.

Daniele Pala, Paola Vicini, Matteo Incerti, 2017, Journal of medicinal chemistry.

Synthesis and QSAR of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates

Giorgio, A. Duranti, M. Mor, 2013 .

as fatty acid amide (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability.

A. Duranti, A. Tontini, M. Mor, 2013 .

Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability.

A. Duranti, A. Tontini, M. Mor, 2011, European journal of medicinal chemistry.

Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma.

M. Lulli, F. Bianchini, Jessica Ruzzolini, 2019, Cancer letters.

Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism

A. Hohmann, A. Duranti, A. Tontini, 2010, Nature Neuroscience.

Pharmacological inhibition of FAAH activity in rodents: A promising pharmacological approach for psychological—cardiac comorbidity?

J. Thayer, A. Sgoifo, M. Mor, 2017, Neuroscience & Biobehavioral Reviews.

UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice

R. Sferra, M. Rusnati, P. Chiodelli, 2018, Oncotarget.

Potent, Metabolically Stable 2‐Alkyl‐8‐(2H‐1,2,3‐triazol‐2‐yl)‐9H‐adenines as Adenosine A2A Receptor Ligands

G. Tarzia, M. Bassi, W. Cabri, 2015, ChemMedChem.

Synthesis of Novel c(AmpRGD)-Sunitinib Dual Conjugates as Molecular Tools Targeting the αvβ3 Integrin/VEGFR2 Couple and Impairing Tumor-Associated Angiogenesis.

A. Pupi, F. Bianchini, L. Battistini, 2017, Journal of medicinal chemistry.

On the selection of an opioid for local skin analgesia: Structure-skin permeability relationships.

G. Vistoli, P. Minghetti, U. Musazzi, 2015, International journal of pharmaceutics.

Novel irreversible epidermal growth factor receptor inhibitors by chemical modulation of the cysteine-trap portion.

A. Ardizzoni, M. Mor, C. Carmi, 2010, Journal of medicinal chemistry.

The GABAB receptor positive allosteric modulator COR659: in vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivatives.

M. Mor, F. Corelli, P. Maccioni, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[18F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma

R. Moresco, S. Valtorta, A. Coliva, 2021, Frontiers in Oncology.

Steps towards sustainable solid phase peptide synthesis: use and recovery of N-octyl pyrrolidone

M. Mor, W. Cabri, A. Ricci, 2021 .

Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery.

G. Lamichhane, A. Kaushik, Marco Pieroni, 2017, Journal of medicinal chemistry.

Synthesis and Structure - Activity Relationships of N - ( 2-Oxo-3-oxetanyl ) amides as N -Acylethanolamine-hydrolyzing Acid Amidase Inhibitors in activated inflammatory cells and

A. Duranti, A. Tontini, M. Mor, 2010 .

Correction to Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo.

M. Mor, V. Di Marzo, S. Lamponi, 2020, Journal of Medicinal Chemistry.

Brain Pharmacokinetics of Non‐Imidazole Biphenyl H3 Receptor Antagonists: a Liquid Chromatography/Electrospray‐Mass Spectrometry and ex vivo Binding Study in Rats

M. Mor, L. Flammini, V. Ballabeni, 2012, Chemistry & biodiversity.

Social stress contagion in rats: Behavioural, autonomic and neuroendocrine correlates

N. Montano, A. Sgoifo, L. Carnevali, 2017, Psychoneuroendocrinology.

Δ(5)-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system.

M. Mor, M. Rusnati, M. Incerti, 2015, European journal of medicinal chemistry.

Palladium catalyst recycling for Heck-Cassar-Sonogashira cross coupling reactions in the green N-hydrohyethyl pyrrolidone/H2O/N,N,N',N'-tetramethyl guanidine blend.

M. Mor, W. Cabri, A. Ricci, 2021, ChemSusChem.

Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.

Claudia Silva, Silvia Rivara, Marco Mor, 2003, Journal of medicinal chemistry.

Predicting the reactivity of nitrile-carrying compounds with cysteine: a combined computational and experimental study.

A. Cavalli, M. Mor, M. Bassi, 2014, ACS medicinal chemistry letters.

Combined targeting of fatty acid amide hydrolase and melatonin receptors promotes neuroprotection and stimulates inflammation resolution in rats

M. Mor, K. Varani, F. Vincenzi, 2022, British journal of pharmacology.

Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety

E. Macchi, A. Sgoifo, M. Mor, 2015, Scientific Reports.

Indole‐based analogs of melatonin: in vitro antioxidant and cytoprotective activities

M. Mor, G. Tarzia, M. Zusso, 2004, Journal of pineal research.

A sulfonyl fluoride derivative inhibits EGFRL858R/T790M/C797S by covalent modification of the catalytic lysine.

M. Tiseo, M. Mor, P. Petronini, 2021, European journal of medicinal chemistry.

Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatization.

T. Dick, Marco Pieroni, G. Costantino, 2022, European journal of medicinal chemistry.

Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties.

M. Rusnati, P. Chiodelli, M. Incerti, 2020, European journal of medicinal chemistry.

Free-energy studies reveal a possible mechanism for oxidation-dependent inhibition of MGL

M. Mor, D. Piomelli, K. Jung, 2016, Scientific Reports.

Peroxide-Dependent MGL Sulfenylation Regulates 2-AG-Mediated Endocannabinoid Signaling in Brain Neurons.

A. Basit, M. Mor, D. Piomelli, 2015, Chemistry & biology.

Amino Acid Derivatives as Palmitoylethanolamide Prodrugs: Synthesis, In Vitro Metabolism and In Vivo Plasma Profile in Rats

M. Mor, M. Bassi, C. Carmi, 2015, PloS one.

Targeting glioblastoma with UniPR1331, a new and stable bioavailable small molecule inhibiting Eph–ephrin interaction: In vitro and in vivo evidence

M. Rusnati, P. Chiodelli, E. Barocelli, 2016 .

Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors.

M. Mor, M. Presta, R. Ronca, 2016, Journal of medicinal chemistry.

Structure-property relationships on histamine H3-antagonists: binding of phenyl-substituted alkylthioimidazole derivatives to rat plasma proteins.

M. Mor, A. Caretta, S. Rivara, 2000, Farmaco.

Synthesis and three-dimensional quantitative structure-activity relationship analysis of H3 receptor antagonists containing a neutral heterocyclic polar group.

P. Carrupt, B. Testa, M. Mor, 2003, Drug design and discovery.

Systematic Modification of the Substitution Pattern of the 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Scaffold Enabled the Discovery of New Ligands with High Affinity and Selectivity for the Cannabinoid Type 2 Receptor

M. Mor, A. Ligresti, F. Corelli, 2023, Molecules.

Irreversible inhibition of epidermal growth factor receptor activity by 3-aminopropanamides.

A. Ardizzoni, M. Mor, G. Costantino, 2012, Journal of medicinal chemistry.

Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism

A. Hohmann, A. Duranti, A. Tontini, 2010, Nature Neuroscience.

A Second Generation of Carbamate‐Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivo

A. Duranti, A. Tontini, M. Mor, 2009, ChemMedChem.

Combining Ligand- and Structure-Based Approaches for the Discovery of New Inhibitors of the EPHA2-ephrin-A1 Interaction

M. Mor, M. Incerti, A. Lodola, 2014, J. Chem. Inf. Model..

Brain Pharmacokinetics of Non‐Imidazole Biphenyl H3 Receptor Antagonists: a Liquid Chromatography/Electrospray‐Mass Spectrometry and ex vivo Binding Study in Rats

M. Mor, L. Flammini, V. Ballabeni, 2012, Chemistry & biodiversity.

Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models

M. Tiseo, P. Petronini, L. Flammini, 2024, Scientific reports.

Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines.

M. Tiseo, C. Fumarola, M. Bonelli, 2024, Biochemical pharmacology.

Disentangling the interactions between nasopharyngeal and gut microbiome and their involvement in the modulation of COVID-19 infection

M. Mor, F. Turroni, M. Ventura, 2023, Microbiology spectrum.

Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.

A. Duranti, A. Tontini, M. Mor, 2008, Journal of medicinal chemistry.

Discovery of novel FGF trap small molecules endowed with anti-myeloma activity.

M. Rusnati, R. Ronca, A. Giacomini, 2024, Pharmacological research.

Enhancement of peripheral fatty acyl ethanolamide signaling prevents stress-induced social avoidance and anxiety-like behaviors in male rats.

A. Sgoifo, Yannick Fotio, F. Vacondio, 2023, Psychopharmacology.

Investigating drug-gut microbiota interactions: Reductive and hydrolytic metabolism of oral glucocorticoids by in vitro artificial gut microbiota.

F. Turroni, M. Ventura, C. Milani, 2024, International journal of pharmaceutics.

Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H3 antagonist ROS203 in rat plasma.

M. Mor, L. Flammini, V. Ballabeni, 2008, Journal of pharmaceutical and biomedical analysis.